aTyr Pharma

IPO

Evolutionary Intelligence

Public · San Diego, United States · Founded 2005 · $76.0M raised

Employees
51–200
Founded
2005
Business Model
B2B
Total Funding
$76.0M
Last Round
$76.0M Series EApr 2015
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Biopharmaceutical company developing therapies based on aminoacyl-tRNA synthetase biology for rare inflammatory diseases.

Summary

aTyr Pharma is a Biotech company based in San Diego, United States, founded in 2005. It has raised $76.0M in total across 1 round, most recently a $76.0M Series E round in Apr 2015. Investors include RBC Capital Markets, Alta Partners and Cardinal Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Secondary MarketSecondary MarketFeb 2023

Sign up to see all 5 events

Funding: Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

aTyr Pharma on Indexed.vc
<a href="https://indexed.vc/companies/atyr-pharma"><img src="https://indexed.vc/api/badge/company/atyr-pharma" alt="aTyr Pharma on Indexed.vc" width="260" height="76" /></a>